Auteur Topic: Miljoenen deal voor Muis Model  (gelezen 2252 keer)


  • Jr. Member
  • **
  • Berichten: 218
  • Geslacht: Vrouw
  • Waar een wil is, is een weg!
Miljoenen deal voor Muis Model
« Gepost op: juni 11, 2009, 16:50:34 »
Op staat het volgende:

MultiMillion Dollar Commitment Spurs First Ever Mouse Model

Studies at University of Chicago’s Unique Celiac Disease Center
University of Chicago Celiac Disease Center Advisory Board Campaign Aims to Uncover
New Treatments for World’s Most Common Genetic Autoimmune Disease

CHICAGO (May 27, 2009) – The University of Chicago Celiac Disease Center Advisory
Board has partnered with The University to launch a two million dollar campaign to
support the first ever mouse model for celiac disease, the world’s most common genetic
autoimmune disease. Celiac disease affects approximately three million Americans and is
triggered by the consumption of glutena protein found in wheat, barley and rye.
For the first time, researchers at the University of Chicago Celiac Disease Center will
examine the underlying causes of the disease, test new therapies and identify new targets
for treatment through mouse model research. Currently a glutenfree diet is only known
treatment for celiac disease, offering only partial allevation of symptoms.
At least ninety seven percent of people with celiac disease have not been diagnosed. The
symptoms are numerous, ranging from intestinal symptoms to neurological and
psychological disorders. If undiagnosed and untreated, it can lead to osteoporosis,
infertility, neurological conditions, and cancer. In addition, patients with celiac disease
have a significantly higher chance of developing other autoimmune diseases, in particular
Type 1 diabetes.

Bana Jabri, M.D., Ph.D., Associate Professor, University of Chicago Medical Center, one of the
world’s leading celiac disease researchers, will develop the new mouse model with the goal
of identifying new remedies and preventive treatments aimed at children of families with
celiac disease history. The studies will also shed new light on events triggering the
development of Type 1 diabetes.

The University of Chicago Celiac Disease Center is the first of its kind in the country. It has
been dedicated to raising awareness and meeting the needs of those affected by the disease
nationwide through education, research and advocacy since 2001.

“There is a critical need to provide the proper resources to those who suffer from celiac
disease,” said Stefano Guandalini, M.D., professor of pediatrics at the University of Chicago
Medical Center, founder and medical director of the Celiac Disease Center. “This
commitment from University of Chicago Celiac Advisory Board reaffirms the Celiac Disease
Center’s mission to bring cutting edge research, education and encouragement to those
affected by the disease”.

Dr. Jabri believes it is essential to create a mouse model of celiac disease to better
understand the chain of events leading to celiac disease, its link to autoimmune diseases,
and provide sustainable funds to continue programming for many years to come.

About the University of Chicago Celiac Disease Center

The University of Chicago Celiac Disease Center has fundamentally improved the care,
diagnosis and awareness of celiac disease. In addition, it provides the infrastructure and
support that is needed to advance cutting‐edge celiac research, including investigations
into structure of gluten peptides and the mechanisms by which gluten modifies self
molecules. The University of Chicago Celiac Disease Center is a 501‐c3 non‐profit
organization, completely funded by donor contributions.
For more information please visit:
Sinds januari 2007 gluten- en lactose vrij. Vanaf september 2007 alleen nog maar glutenvrij.